S. Fazeli Farsani, K. Brodovicz, N. Soleymanlou et al. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open 7, e016587 (2017)
A.E. Kitabchi, G.E. Umpierrez, J.M. Miles, J.N. Fisher, Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32, 1335–43 (2009)
Article CAS PubMed PubMed Central Google Scholar
K.K. Dhatariya, Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults-an updated guideline from the joint British diabetes society for inpatient care. Diabet Med 39, e14788 (2022)
Y. Handelsman, R.R. Henry, Z.T. Bloomgarden, D. LeRoith, G.E. Umipierrez, M.R. Weir et al. American association of clinical endocrinologists and American College of endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. Endocr Pract 22, 753–62 (2016)
American Diabetes Association Professional Practice Committee, 16. diabetes care in the hospital: standards of medical care in diabetes-2022. Diabetes Care 45(Suppl 1), S244–53 (2022)
G. Umpierrez, M. Korytkowski, Diabetic emergencies-ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 12, 222–32 (2016)
Article CAS PubMed Google Scholar
A. Modi, A. Agrawal, F. Morgan, Euglycemic diabetic ketoacidosis: A review. Curr Diabetes Rev 13, 315–21 (2017)
Article CAS PubMed Google Scholar
L. Barski, T. Eshkoli, E. Brandstaetter, A. Jotkowitz, Euglycemic diabetic ketoacidosis. Eur J Intern Med 63, 9–14 (2019)
C. Hurlock-Chorostecki, Managing diabetic ketoacidosis: the role of the ICU nurse in an endocrine emergency. Dynamics 15, 18–22 (2004)
J.L. Kelly, Continuous insulin infusion: when, where, and how? Diabetes Spectr 27, 218–23 (2014)
Article PubMed PubMed Central Google Scholar
T Donner, S Sarkar, Insulin – pharmacology, therapeutic regimens, and principles of intensive insulin therapy. South Dartmouth (MA): MDText.com, Inc.
C.A. Andrade-Castellanos, L.E. Colunga-Lozano, N. Delgado-Figueroa, D.A. Gonzalez-Padilla, Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev 2016, CD011281 (2016)
PubMed PubMed Central Google Scholar
Z. Razavi, S. Maher, J. Friedman, Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients. Endocrine 81, 267–74 (2018).
L. Cardoso, N. Vicente, D. Rodrigues, L. Gomes, F. Carrilho, Controversies in the management of hyperglycaemic emergencies in adults with diabetes. Metabolism 68, 43–54 (2017)
Article CAS PubMed Google Scholar
P. Rao, S.-F. Jiang, P. Kipnis, D.M. Patel, S. Katsnelson, S. Madani et al. Evaluation of outcomes following hospital-wide implementation of a subcutaneous insulin protocol for diabetic ketoacidosis. JAMA Netw Open 5, e226417 (2022)
Article PubMed PubMed Central Google Scholar
T.V. Pereira, J.P.A. Ioannidis, Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects. J Clin Epidemiol 64, 1060–9 (2011)
A. Afshari, J. Wetterslev, A.F. Smith, Can systematic reviews with sparse data be trusted? Anaesthesia 72, 12–6 (2017)
Article CAS PubMed Google Scholar
J. Wetterslev, J.C. Jakobsen, C. Gluud, Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol 17, 39 (2017)
Article PubMed PubMed Central Google Scholar
A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, J.P.A. Loannidis et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. BMJ 339, b2700 (2009)
Article PubMed PubMed Central Google Scholar
B.L. Lim, W.F. Lee, B. Lee, Y.E. Lynette Chung, K.V. Loo, Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials. BMJ Open 13, e070131 (2023). https://doi.org/10.1136/bmjopen-2022-070131
Article PubMed PubMed Central Google Scholar
E Karslioglu E French, AC Donihi, MT Korytkowski, Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ 2019:l1114
Cochrane Effective Practice and Organisation of Care (EPOC). Data collection form. EPOC resources for review authors. 2021. Available: epoc.cochrane.org/resources/epoc-specific-resources-review-authors [Accessed 19 Sep 2022]
J.P.T. Higgins, D.G. Altman, P.C. Gøtzsche, P. Jüni, D. Moher, A.D. Oxman et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343, d5928 (2011)
Article PubMed PubMed Central Google Scholar
G.H. Guyatt, A.D. Oxman, G.E. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336, 924–6 (2008)
Article PubMed PubMed Central Google Scholar
X. Wan, W.Q. Wang, J.M. Liu, T.J. Tong, Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14, 135 (2014)
Article PubMed PubMed Central Google Scholar
S.P. Hozo, B. Djulbegovic, I. Hozo, Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5, 13 (2005)
Article PubMed PubMed Central Google Scholar
M. Bland, Estimating mean and standard deviation from the sample size, three quartiles, minimum, and maximum. Int J Stats in Med Res 4, 57–64 (2015)
J.P. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman, Measuring inconsistency in meta-analyses. BMJ 327, 557–60 (2003)
Article PubMed PubMed Central Google Scholar
D.G. Altman, J.M. Bland, Interaction revisited: the difference between two estimates. BMJ 326, 219 (2003)
Article PubMed PubMed Central Google Scholar
G.E. Umpierrez, R. Cuervo, A. Karabell, K. Latif, A.X. Freire, A.E. Kitabchi, Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care 27, 1873–8 (2004)
Article CAS PubMed Google Scholar
G.E. Umpierrez, K. Latif, J. Stoever, R. Cuervo, L. Park, A.X. Freire et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 117, 291–6 (2004)
Article CAS PubMed Google Scholar
T. Della Manna, L. Steinmetz, P.R. Campos, S.C. Farhat, C. Schvartsman, H. Kuperman et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care 28, 1856–61 (2005)
H.O. Ersöz, K. Ukinc, M. Köse, C. Erem, A. Gunduz, A.B. Hacihasanoglu et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract 60, 429–33 (2006)
R. Karoli, J. Fatima, T. Salman, S. Sandhu, R. Shankar, Managing diabetic ketoacidosis in non-intensive care unit setting: Role of insulin analogs. Indian J Pharmacol 43, 398–401 (2011)
Article CAS PubMed PubMed Central Google Scholar
I. Ahmed, S. Sabir Ali, Z. Ali, N. Mohammad, T. Ghaffar, Management of diabetic ketoacidosis: role of rapid acting insulin analogs in comparison to regular intravenous insulin. Int J Endorsing Health Sci Res 9, 76–82 (2021). 2021
D. Desai, D. Mehta, P. Mathias, G. Menon, U.K. Schubart, Health care utilization and burden of diabetic ketoacidosis in the US over the past decade: a nationwide analysis. Diabetes Care 41, 1631–8 (2018)
留言 (0)